FundedIQ
Biotechnology

VRG Therapeutics: Funding, Investors & Team (Sep 2026)

VRG Therapeutics is a biotech firm specializing in miniprotein-based drugs and cellular and gene therapy technologies.

vrgtherapeutics.com LinkedIn Budapest, Hungary 11-50 employees
Total raised
$5.5M
Rounds
1
Latest
Series A
Aug 2023

VRG Therapeutics has raised $5.5M across 1 funding round on record, the most recent a Series A of $5.5M announced in Aug 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

VRG Therapeutics Company Profile and Key Stats

Total funding raised
$5.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$5.5M in Aug 2023
Employees
11-50
reported band
Headquarters
Budapest, Hungary

Latest funding round on record: Aug 2023.

VRG Therapeutics Funding Rounds

Date
Round
Amount
Series A
$5.5M

VRG Therapeutics Founders and Leadership Team

Name
Role
Contact
Anna Hajdara
Founder

No contact details are on record for this team yet.

VRG Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
42
$7.2M
8,352
$15M

VRG Therapeutics' latest round of $5.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like VRG Therapeutics in Biotechnology and Budapest

Companies Similar to VRG Therapeutics

Ubives is an innovative user management tool that transforms the way online identification and data…

Pre-Seed $10k

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…

Seed $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…

Series A $40.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…

Series B $15.5M

Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…

Series B $7.3M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

VRG Therapeutics Funding FAQs

What does VRG Therapeutics do?

VRG Therapeutics is a biotech firm specializing in miniprotein-based drugs and cellular and gene therapy technologies.

How much funding has VRG Therapeutics raised?

VRG Therapeutics has raised $5.5M across 1 round on record. The most recent is a Series A of $5.5M announced in Aug 2023.

When did VRG Therapeutics last raise funding?

VRG Therapeutics' most recent funding round on record is a Series A of $5.5M, announced in Aug 2023.

Who founded VRG Therapeutics?

FundedIQ lists Anna Hajdara (Founder) at VRG Therapeutics.

Where is VRG Therapeutics headquartered?

VRG Therapeutics is based in Budapest, Hungary.

How many employees does VRG Therapeutics have?

VRG Therapeutics is in the 11-50 employee band.

How does VRG Therapeutics' funding compare to other Biotechnology startups?

VRG Therapeutics' latest round of $5.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's VRG Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VRG Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.